Review Article
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
(a) Potential first- and second-line NRTI backbones for HIV-2 and dual infection |
| First-line | Second-line |
| AZT/3TC | TDF/AZT/3TC or FTC | TDF/FTC or 3TC* | TDF/AZT/3TC or FTC | ABC/3TC | TDF/AZT/3TC or FTC |
|
|
*FTC and 3TC are assumed to be essentially equivalent in the table, despite FTC’s possible superiority and 3TC’s possibly lower cost.
|
(b) Potential first- and second-line PIs for HIV-2 and dual infection |
| First-line | Second-line |
| LPV/r | SQV/r or DRV/r | SQV/r | LPV/r or DRV/r | IDV/r | LPV/r or SQV/r or DRV/r |
|
|